Prenatal Valproate Exposure May Boost ADHD Risk by Almost 50%

New research adds to the growing body of evidence that prenatal exposure to the anti-epileptic drug valproate increases the risk of adverse neurodevelopmental effects in offspring.
Medscape Medical News

Source link

Related posts

Spotlight on the April 7 issue


Two closely spaced mutations in cis result in Ullrich congenital muscular dystrophy


Long-term follow-up for multiple sclerosis patients initially treated with interferon-beta and glatiramer acetate


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy